New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Introduction Antibiotic-resistant bacteria are a growing global threat, causing longer hospital stays, higher costs, and increased mortality. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria—such as…

Continue ReadingNew Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Role of liposomal amphotericin B in intensive care unit: an expert opinion paper

Introduction Invasive fungal infections (IFI) are life-threatening in ICU patients, with rising incidence and persistently high mortality. The increase is linked to complex care needs, immunocompromised states, comorbidities, broad-spectrum antibiotic…

Continue ReadingRole of liposomal amphotericin B in intensive care unit: an expert opinion paper

Current role of ceftobiprole in the treatment of hospital acquired and community acquired pneumonia: expert opinion based on literature and real-life experiences

Introduction (Article introduction authored by INCA Editorial Team) Bacterial pneumonia remains a global health challenge with high morbidity and mortality, particularly in vulnerable populations. Community-acquired pneumonia (CAP) and hospital-acquired pneumonia…

Continue ReadingCurrent role of ceftobiprole in the treatment of hospital acquired and community acquired pneumonia: expert opinion based on literature and real-life experiences